Thirty-Day Mortality After Curative and Palliative Anti-Cancer Treatment: Data Interpretation and Lessons for Clinical Implementation.

Tashkandi, Emad; Basulaiman, Bassam; Alghareeb, Waleed; Hamadi, Faris; Alghamdi, Anas; Albabakri, Faez; Alshabi, Redhwan; Jaffal, Mohammad; Albaradie, Abdulrahman; Azher, Ruqayya

Tashkandi, Emad; Basulaiman, Bassam; Alghareeb, Waleed; Hamadi, Faris; Alghamdi, Anas; Albabakri, Faez; Alshabi, Redhwan; Jaffal, Mohammad; Albaradie, Abdulrahman; Azher, Ruqayya.

Affiliation

Tashkandi E; Umm AlQura University, College of Medicine, Makkah, Saudi Arabia.
Basulaiman B; King Abdullah Medical City, Oncology Center, Makkah, Saudi Arabia.
Alghareeb W; Comprehensive Cancer Center, Medical Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.
Hamadi F; Comprehensive Cancer Center, Medical Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.
Alghamdi A; Comprehensive Cancer Center, Medical Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.
Albabakri F; Comprehensive Cancer Center, Medical Oncology, King Fahad Medical City, Riyadh, Saudi Arabia.
Alshabi R; King Abdullah Medical City, Oncology Center, Makkah, Saudi Arabia.
Jaffal M; King Abdullah Medical City, Oncology Center, Makkah, Saudi Arabia.
Albaradie A; King Abdullah Medical City, Oncology Center, Makkah, Saudi Arabia.
Azher R; King Abdullah Medical City, Oncology Center, Makkah, Saudi Arabia.

Cancer Manag Res ; 12: 12301-12308, 2020.

Article de En | MEDLINE | ID: mdl-33293858

Mots clés

cancer; chemotherapy; individual outcome; morbidity; predictive preventive personalized medicine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Cancer Manag Res Année: 2020 Type de document: Article Pays d'affiliation: Arabie saoudite

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google